相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche
Amber Jin Giles et al.
CANCER RESEARCH (2016)
Risks and Benefits of Bisphosphonate Therapies
Carlen Reyes et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer
Mitsuru Futakuchi et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Targeted delivery to bone and mineral deposits using bisphosphonate ligands
Lisa E. Cole et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
Quanyin Hu et al.
ADVANCED MATERIALS (2016)
Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo
Tsutomu Nakazawa et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines
M. Fragni et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
Heleen. H. Van Acker et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX
Domenica Rea et al.
BIOMED RESEARCH INTERNATIONAL (2016)
The Bone Microenvironment: a Fertile Soil for Tumor Growth
Denise Buenrostro et al.
CURRENT OSTEOPOROSIS REPORTS (2016)
Potential of targeted drug delivery system for the treatment of bone metastasis
Raichur Vinay et al.
DRUG DELIVERY (2016)
Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma
Atik Badshah Shaikh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Synthesis and Preliminary in Vivo Evaluation of Well-Dispersed Biomimetic Nanocrystalline Apatites Labeled with Positron Emission Tomographic Imaging Agents
Benedikt Sandhoefer et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Hydroxyapatite nanocrystals functionalized with alendronate as bioactive components for bone implant coatings to decrease osteoclastic activity
Ruggero Bosco et al.
APPLIED SURFACE SCIENCE (2015)
Tumor-Induced Pressure in the Bone Microenvironment Causes Osteocytes to Promote the Growth of Prostate Cancer Bone Metastases
Joseph L. Sottnik et al.
CANCER RESEARCH (2015)
Crosstalk between bone niche and immune system: Osteoimmunology signaling as a potential target for cancer treatment
Carmen Criscitiello et al.
CANCER TREATMENT REVIEWS (2015)
Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering
Dmitri A. Ossipov
EXPERT OPINION ON DRUG DELIVERY (2015)
In vitro and in vivo toxicity of 5-FdU-alendronate, a novel cytotoxic bone-seeking duplex drug against bone metastasis
Sarah Schott et al.
INVESTIGATIONAL NEW DRUGS (2015)
New therapeutic targets for cancer bone metastasis
Jing Y. Krzeszinski et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Charge and Hydrophobicity Effects of NIR Fluorophores on Bone-Specific Imaging
Kai Bao et al.
THERANOSTICS (2015)
Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy
Heleen H. Van Acker et al.
ONCOIMMUNOLOGY (2015)
Multimodal imaging of bone metastases: From preclinical to clinical applications
Stephan Ellmann et al.
JOURNAL OF ORTHOPAEDIC TRANSLATION (2015)
Treatment of multiple myeloma bone disease: experimental and clinical data
Yvonne Mary Papamerkouriou et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages
Yoshiyuki Hattori et al.
JOURNAL OF LIPOSOME RESEARCH (2015)
Real-Time Intravital Imaging Establishes Tumor-Associated Macrophages as the Extraskeletal Target of Bisphosphonate Action in Cancer
Simon Junankar et al.
CANCER DISCOVERY (2015)
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence
Daniele Santini et al.
BREAST CANCER RESEARCH (2015)
Patient-derived xenograft models of breast cancer and their predictive power
James R. Whittle et al.
BREAST CANCER RESEARCH (2015)
Synergistic effects of bisphosphonate and calcium phosphate nanoparticles on peri-implant bone responses in osteoporotic rats
Hamdan S. Alghamdi et al.
BIOMATERIALS (2014)
Pure anti-tumor effect of zoledronic acid in na⟨ve bone-only metastatic and locally advanced breast cancer: proof from the biological window therapy
Chiara Foroni et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma
Qing-Min Fan et al.
CANCER LETTERS (2014)
Forkhead Box Q1 Promotes Hepatocellular Carcinoma Metastasis by Transactivating ZEB2 and VersicanV1 Expression
Limin Xia et al.
HEPATOLOGY (2014)
Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo
Xuesong Wu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Bisphosphonamidate Clodronate Prodrug Exhibits Selective Cytotoxic Activity against Melanoma Cell Lines
Marie R. Webster et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
Haihui Lu et al.
NATURE CELL BIOLOGY (2014)
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
Raffaella Sabatino et al.
PLOS ONE (2014)
Bisphosphonates inactivate human EGFRs to exert antitumor actions
Tony Yuen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Engineered nanomedicine for myeloma and bone microenvironment targeting
Archana Swami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer
Agnes Stachnik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin
Yifeng Xia et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Osteotropic Therapy via Targeted Layer-by-Layer Nanoparticles
Stephen W. Morton et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Polymer therapeutics-prospects for 21st century: The end of the beginning
Ruth Duncan et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Modular 'Click-in-Emulsion' Bone-Targeted Nanogels
Daniel A. Heller et al.
ADVANCED MATERIALS (2013)
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
Michael McClung et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases
Keren Miller et al.
BIOMATERIALS (2013)
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
Malgorzata Banys et al.
BMC CANCER (2013)
Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration
Wenyi Gu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates
Naomi Gronich et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer
Kohei Hashimoto et al.
PROSTATE (2013)
Bionanomaterials for bone tumor engineering and tumor destruction
Gary Blackburn et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Targeting polymer therapeutics to bone
Stewart A. Low et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Nanoparticle and targeted systems for cancer therapy
Lisa Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid
P. G. Dedes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Oriented Immobilization of Proteins on Hydroxyapatite Surface Using Bifunctional Bisphosphonates as Linkers
Jivan N. Yewle et al.
BIOMACROMOLECULES (2012)
Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer
Sanjay I. Thamake et al.
BIOMATERIALS (2012)
Methylene diphosphonate-conjugated adriamycin liposomes: preparation, characteristics, and targeted therapy for osteosarcomas in vitro and in vivo
Daocheng Wu et al.
BIOMEDICAL MICRODEVICES (2012)
Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis
Steve Arns et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study
Monica Marra et al.
BIOTECHNOLOGY ADVANCES (2012)
Macrophages in Tumor Microenvironments and the Progression of Tumors
Ning-Bo Hao et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Bone Target Radiotracers for Palliative Therapy of Bone Metastases
K. Ogawa et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Nanoparticles and their potential for application in bone
Andrea Tautzenberger et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells
Lavinia Insalaco et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Bone metastasis targeting: A novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel
Kiran Ramanlal Chaudhari et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass
Min Guan et al.
NATURE MEDICINE (2012)
Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions
Dionysios J. Papachristou et al.
MEDICINAL RESEARCH REVIEWS (2012)
Synthesis and Biological Evaluation of a New Polymeric Conjugate and Nanocarrier with Osteotropic Properties
Rosario Pignatello et al.
JOURNAL OF FUNCTIONAL BIOMATERIALS (2012)
In-vivo near-infrared optical imaging of growing osteosarcoma cell lesions xenografted in mice: dual-channel quantitative evaluation of volume and mineralization
Hitoshi Nakayama et al.
ACTA RADIOLOGICA (2011)
Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances
Ehud Segal et al.
BIOMATERIALS (2011)
N4-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-New drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate)
Herbert Schott et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
The relationship between the chemistry and biological activity of the bisphosphonates
Frank H. Ebetino et al.
BONE (2011)
Bisphosphonates: The first 40 years
R. Graham G. Russell
BONE (2011)
Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis
E. Michael Lewiecki
DRUGS (2011)
Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting
Maha Nasr et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors
G. Salzano et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Tumour macrophages as potential targets of bisphosphonates
Thea L. Rogers et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Bisphosphonates as radionuclide carriers for imaging or systemic therapy
Elisa Palma et al.
MOLECULAR BIOSYSTEMS (2011)
Antiangiogenic Antitumor Activity of HPMA Copolymer-Paclitaxel-Alendronate Conjugate on Breast Cancer Bone Metastasis Mouse Model
Keren Miller et al.
MOLECULAR PHARMACEUTICS (2011)
Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms
Chiara Clementi et al.
MOLECULAR PHARMACEUTICS (2011)
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes
Monica Marra et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Affinity of hydroxyapatite (001) and (010) surfaces to formic and alendronic acids: a quantum-mechanical and infrared study
Pieremanuele Canepa et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2011)
The Reaction of Bone to Tumor Growth From Human Breast Cancer Cells in a Rat Spine Single Metastasis Model
Haixiang Liang et al.
SPINE (2011)
Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs
Scott Hafeman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy
Yuru Meng et al.
CANCER RESEARCH (2010)
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases
M. Salerno et al.
CURRENT CANCER DRUG TARGETS (2010)
Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
A. J. Roelofs et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma
Michele Moschetta et al.
EUROPEAN JOURNAL OF CANCER (2010)
The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation
Andreas Guenther et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Development of a novel poly bisphosphonate conjugate for treatment of skeletal metastasis and osteoporosis
Anders R. Holmberg et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Structural requirements for bisphosphonate actions in vitro
Ermond van Beek et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Near-Infrared Fluorescent Probe Traces Bisphosphonate Delivery and Retention In Vivo
Kenneth M. Kozloff et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
Marta Coscia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
Rebecca Aft et al.
LANCET ONCOLOGY (2010)
Bone health and prostate cancer
P. J. Saylor et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Targeting Bone Metastases with a Bispecific Anticancer and Antiangiogenic Polymer-Alendronate-Taxane Conjugate
Keren Miller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention
Florence Daubine et al.
BIOMATERIALS (2009)
Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro
Johanna Raikkonen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases
Makoto Kawatani et al.
CANCER SCIENCE (2009)
Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases
R. Torres Martin de Rosales et al.
CHEMICAL COMMUNICATIONS (2009)
Improved Bone Delivery of Osteoprotegerin by Bisphosphonate Conjugation in a Rat Model of Osteoarthritis
Michael R. Doschak et al.
MOLECULAR PHARMACEUTICS (2009)
A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate
Rosario Pignatello et al.
NANOMEDICINE (2009)
Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics
Ehud Segal et al.
PLOS ONE (2009)
Ligand-modified aminobisphosphonate for linking proteins to hydroxyapatite and bone surface
Robin S. Ehrick et al.
BIOCONJUGATE CHEMISTRY (2008)
Fluorescently Labeled Risedronate and Related Analogues: Magic Linker Synthesis
Boris A. Kashemirov et al.
BIOCONJUGATE CHEMISTRY (2008)
Chemotherapeutic bone-targeted bisphosphonate prodrugs with hydrolytic mode of activation
Rotem Erez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Emerging robe of bisphosphonates in the clinic - Antitumor activity and prevention of metastasis to bone
Allan Lipton
CANCER TREATMENT REVIEWS (2008)
BKM1740, an Acyl-Tyrosine Bisphosphonate Amide Derivative, Inhibits the Bone Metastatic Growth of Human Prostate Cancer Cells by Inducing Apoptosis
Seong Il Seo et al.
CLINICAL CANCER RESEARCH (2008)
Polymeric nanoparticles for cancer therapy
Suphiya Parveen et al.
JOURNAL OF DRUG TARGETING (2008)
Linking Bisphosphonates to the Free Amino Groups in Fluoroquinolones: Preparation of Osteotropic Prodrugs for the Prevention of Osteomyelitis
Tom J. Houghton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate
Michele Iafisco et al.
LANGMUIR (2008)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Anti-tumor cytotoxicity of γδ T cells expanded from peripheral blood cells of patients with myeloma and lymphoma
Anri Saitoh et al.
MEDICAL ONCOLOGY (2008)
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma
Claudio Scavelli et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone
Sung-Wook Choi et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Zoledronic acid-induced IPP/ApppI production in vivo
Hannu Monkkonen et al.
LIFE SCIENCES (2007)
Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients
Daniele Santini et al.
CLINICAL CANCER RESEARCH (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties
Matthew B. Murphy et al.
BIOMACROMOLECULES (2007)
Experience with bisphosphonates in osteogenesis imperfecta
Francis H. Glorieux
PEDIATRICS (2007)
Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro
M. F. Moreau et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Synthesis of conjugatable bisphosphonates for molecular imaging of large animals
Kumar R. Bhushan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
New developments of aminobisphosphonates: the double face of Janus
D. Santini et al.
ANNALS OF ONCOLOGY (2007)
Novel therapeutic agents for bone resorption. Part 1. Synthesis and protonation thermodynamics of poly(amido-amine)s containing bis-phosphonate residues
Mario Casolaro et al.
BIOMACROMOLECULES (2006)
Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs
Mark Mathes et al.
EXPERIMENTAL HEMATOLOGY (2006)
Clodronate-liposome-mediated depletion of tumour-associated macrophages:: a new and highly effective antiangiogenic therapy approach
S. M. Zeisberger et al.
BRITISH JOURNAL OF CANCER (2006)
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia et al.
ENDOCRINE-RELATED CANCER (2006)
A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates
H Mönkkönen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
KD Brubaker et al.
BMC CANCER (2006)
Recent advances in understanding the mechanism of action of bisphosphonates
Fraser P. Coxon et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
The dental implications of bisphosphonates and bone disease
A Cheng et al.
AUSTRALIAN DENTAL JOURNAL (2005)
Imparting mineral affinity to fetuin by bisphosphonate conjugation: A comparison of three bisphosphonate conjugation schemes
Sebastien A. Gittens et al.
MOLECULAR PHARMACEUTICS (2005)
Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma - A possible mechanism for its antitumor effect
A Corso et al.
CANCER (2005)
Designing proteins for bone targeting
SA Gittens et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Preclinical investigations of drug and radionuclide conjugates of bisphosphonates for the treatment of metastatic bone cancer
A El-Mabhouh et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates
SA Gittens et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Immune-mediated hemolytic anemia: understanding the nemesis
S McCullough
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2003)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Matrix metalloproteinases: Biologic activity and clinical implications
AR Nelson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
